Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The DNA polymerase activity, and susceptibilities to 9-beta-D-arabinofuranosyladenine(ara-A) and 1-beta-arabinofuranosylcytosine(ara-C) of a phosphonoacetic acid resistant mutant (PAA-R) of varicella-zoster virus (VZV) selected in the presence of
PAA
were examined. The DNA polymerase activity of
PAA
-R was inhibited less than that of the parent strain by
PAA
in vitro.
PAA
-R was resistant to acyclovir and also to both
ara
-A and
ara
-C. The susceptibilities to
ara
-A and
ara
-C of four acyclovir resistant mutants selected in the presence of acyclovir, and also resistant to
PAA
, were examined. Two variants were resistant, one was slightly resistant, and one was sensitive to both drugs. These cross-resistances and susceptibilities of VZV variants to
PAA
, ACV,
ara
-A and
ara
-C should be considered in chemotherapy of VZV infections.
...
PMID:Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine. 302 9